antares4141
Senior Member
- Messages
- 579
- Location
- Truth or consequences, nm
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Abstract
In the course of Parkinson's disease (PD), the enteric nervous system (ENS) and parasympathetic nerves are amongst the structures earliest and most frequently affected by alpha‐synuclein pathology. Accordingly, gastrointestinal dysfunction, in particular constipation, is an important non‐motor symptom in PD and often precedes the onset of motor symptoms by years.
Recent research has shown that intestinal microbiota interact with the autonomic and central nervous system via diverse pathways including the ENS and vagal nerve.
The gut microbiome in PD has not been previously investigated. We compared the fecal microbiomes of 72 PD patients and 72 control subjects by pyrosequencing the V1–V3 regions of the bacterial 16S ribosomal RNA gene.
Associations between clinical parameters and microbiota were analyzed using generalized linear models, taking into account potential confounders.
On average, the abundance of Prevotellaceae in feces of PD patients was reduced by 77.6% as compared with controls. Relative abundance of Prevotellaceae of 6.5% or less had 86.1% sensitivity and 38.9% specificity for PD.
A logistic regression classifier based on the abundance of four bacterial families and the severity of constipation identified PD patients with 66.7% sensitivity and 90.3% specificity. The relative abundance of Enterobacteriaceae was positively associated with the severity of postural instability and gait difficulty.
These findings suggest that the intestinal microbiome is altered in PD and is related to motor phenotype. Further studies are warranted to elucidate the temporal and causal relationships between gut microbiota and PD and the suitability of the microbiome as a biomarker. © 2014 International Parkinson and Movement Disorder Society
Accordingly, gastrointestinal dysfunction, in particular constipation, is an important non‐motor symptom in PD and often precedes the onset of motor symptoms by years.
Ever my opinion is it´s a consequence. More difficult to get a clue though.
Ever my opinion is it´s a consequence. More difficult to get a clue though.
This is not true, sorry for that. The study I thought to referr to is:This year a similar result for depression has been published.
Now, there are influences on depression which do not directly influence the microbiome
This is not true, sorry for that. The study I thought to referr to is:
Pan, Xia et al 2018: "Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitter: a target metabolomics study"
I don´t hope so!This would seem to support the idea that the gut may have a larger role in giving the brain information than the brain in giving the gut information.
It took me a while until I understood that you are not talking about the mentioned alpha-synuclein protein. The protein perhaps wouldn´t care about afferents or efferents, if not interested in traffics.I find it extremely amusing that 80% of all vagus nerves are afferent and only 20% are efferent.
I don´t hope so!
It took me a while until I understood that you are not talking about the mentioned alpha-synuclein protein. The protein perhaps wouldn´t care about afferents or efferents, if not interested in traffics.
Humour aside.
I mainly came up with the idea of a request of products because the body seems to me to be a webb, and even the science has developed rapidly in the past 20 years and with a lot of comfortable succes, the most of the picture is still unknown. And in our case eg there are some hints that the gut would not be the only (underlying) cause (there have been outbreaks, and if the gut theory would be true it needed to explain how a rapid altering of the gut microbiome would have taken place, including the consequencies). Also there are influences and even recoveries known, and especially in the last case I was wondering if this could be explained by an influence on the gut.
However, I hope for the sake of PWPD that the answere would be as simple as the guess, "- still a big if -" though. I don´t know how good the guesses I have read on some different causes of "Parkinson´s diseases" are. Maybe there is a request for the "misfolded" alpha-synuclein,?? “The question is, and it’s still an outstanding question, what is it that these bacteria are producing that is, at least in animals, causing alpha-synuclein to form amyloids?” (quote from the webside, quite at the end).
I admit that the gut might be an interesting or (sometimes?) an important factor.
I don´t hope so!
It took me a while until I understood that you are not talking about the mentioned alpha-synuclein protein. The protein perhaps wouldn´t care about afferents or efferents, if not interested in traffics.
Humour aside.
I mainly came up with the idea of a request of products because the body seems to me to be a webb, and even the science has developed rapidly in the past 20 years and with a lot of comfortable succes, the most of the picture is still unknown. And in our case eg there are some hints that the gut would not be the only (underlying) cause (there have been outbreaks, and if the gut theory would be true it needed to explain how a rapid altering of the gut microbiome would have taken place, including the consequencies). Also there are influences and even recoveries known, and especially in the last case I was wondering if this could be explained by an influence on the gut.
However, I hope for the sake of PWPD that the answere would be as simple as the guess, "- still a big if -" though. I don´t know how good the guesses I have read on some different causes of "Parkinson´s diseases" are. Maybe there is a request for the "misfolded" alpha-synuclein,?? “The question is, and it’s still an outstanding question, what is it that these bacteria are producing that is, at least in animals, causing alpha-synuclein to form amyloids?” (quote from the webside, quite at the end).
I admit that the gut might be an interesting or (sometimes?) an important factor.
I think it’s funny that you have a gut feeling that it’s starting in the brain.
Results: 35/60 patients who underwent initial bacteriotherapy responded to treatment. 10/15 patients who failed this course were offered a secondary transcolonoscopic infusion followed by a rectal infusion or an oral course of cultured bacteria.
Of these 7/10 responded, giving a total of 42/60 (70%) patients who responded to treatment. Contact was achieved with 12 patients after 15-20 year follow-up.
Complete resolution of symptoms was maintained in seven of the twelve patients and 5/12 did not experience recurrence for approximately 1.5-3 years post bacteriotherapy.
Conclusion: Bacteriotherapy achieves initial success rate of 70% in CFS and a 58% sustained response.
Given that manipulation of the colonic microbiota improved CFS symptoms, bacteriotherapy for CFS warrants further investigation and may provide further insight into a possible etiology of CFS.
Also the outcomes might indicate that the gut might be part of a larger cycle.Abstract: Introduction: Chronic Fatigue Syndrome (CFS) has a complex and multifactorial etiology making treatment and definitive diagnosis, currently made through exclusion, difficult.